German biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapyCatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy Share XGerman biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapyhttps://pharmaphorum.com/news/german-biotech-catalym-raises-e50-million-for-gdf-15-inhibitor-immunotherapy/
Kyowa Kirin backs €125m life science fund closed by Fountain HealthcareIreland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – Share XKyowa Kirin backs €125m life science fund closed by Fountain Healthcarehttps://pharmaphorum.com/news/kyowa-kirin-backs-e125m-life-science-fund-closed-by-fountain-healthcare/
Sarepta helps bankroll new gene therapy startup AavantiBioSarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with Share XSarepta helps bankroll new gene therapy startup AavantiBiohttps://pharmaphorum.com/news/sarepta-helps-bankroll-new-gene-therapy-startup-aavantibio/
Chord gets $16m to challenge Alexion with oral NMOSD drugSwiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will Share XChord gets $16m to challenge Alexion with oral NMOSD drughttps://pharmaphorum.com/news/chord-gets-16m-to-challenge-alexion-with-oral-nmosd-drug/
$110m financing sets up US, Asia expansion for Sophia GeneticsSwiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be Share X$110m financing sets up US, Asia expansion for Sophia Geneticshttps://pharmaphorum.com/news/110m-financing-sets-up-us-asia-expansion-for-sophia-genetics/
Digital health firm Lyra enters unicorn territory after fundraisingDigital health startup Lyra Health has raised $110 million in fourth-round financing, raising its value above the $1 Share XDigital health firm Lyra enters unicorn territory after fundraisinghttps://pharmaphorum.com/news/digital-health-firm-lyra-enters-unicorn-territory-after-fundraising/
UK cancer mutation testing firm Biofidelity raises $12mCambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect Share XUK cancer mutation testing firm Biofidelity raises $12mhttps://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/
Novo-backed $61m fundraising helps F2G prep for antifungal launchAnglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening Share XNovo-backed $61m fundraising helps F2G prep for antifungal launchhttps://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/
UK biotech OMass raises £27.5m for GPCR drug discoveryOxford, UK-based OMass Therapeutics has extended its first-round financing to more than £41 million ($53 million), to help Share XUK biotech OMass raises £27.5m for GPCR drug discoveryhttps://pharmaphorum.com/news/uk-biotech-omass-raises-27-5m-for-gpcr-drug-discovery/
